| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Soligenix, Inc., a biopharmaceutical firm in its advanced development stages, concentrates on bringing innovative products to market within the United States, specifically targeting rare illnesses. The company's operations are divided into two main divisions: Specialized BioTherapeutics and Public Health Solutions. Within the Specialized BioTherapeutics division, Soligenix is advancing SGX301 (marketed as HyBryte), a novel photodynamic treatment that has successfully completed its Phase III clinical trials for managing cutaneous T-cell …
Over the last 12 months, insiders at Soligenix, Inc. have bought $0 and sold $0 worth of Soligenix, Inc. stock.
On average, over the past 5 years, insiders at Soligenix, Inc. have bought $26,567 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 15,132 shares for transaction amount of $20,000 was made by SCHABER CHRISTOPHER J (CHAIRMAN, CEO AND PRESIDENT) on 2025‑10‑02.
| 2025-10-02 | SCHABER CHRISTOPHER J | CHAIRMAN, CEO AND PRESIDENT | 15,132 0.5282% | $1.32 | $20,000 | -10.94% | ||
| 2022-05-18 | SCHABER CHRISTOPHER J | CHAIRMAN, CEO AND PRESIDENT | 20,000 0.0466% | $0.44 | $8,866 | +23.81% | ||
| 2022-05-18 | Straube Richard | SENIOR VICE PRESIDENT AND CMO | 8,000 0.021% | $0.50 | $4,000 | +23.81% | ||
| 2021-12-17 | SCHABER CHRISTOPHER J | CHAIRMAN, CEO AND PRESIDENT | 7,000 <0.0001% | $0.74 | $5,179 | -13.05% | ||
| 2021-12-15 | Guarino Jonathan L. | Senior Vice President and CFO | 1,000 <0.0001% | $0.70 | $700 | -10.86% | ||
| 2021-12-14 | SCHABER CHRISTOPHER J | Chairman, CEO and President | 10,000 0.0001% | $0.73 | $7,269 | -7.05% | ||
| 2021-12-14 | Guarino Jonathan L. | Senior Vice President and CFO | 10,000 0.0001% | $0.71 | $7,119 | -7.05% | ||
| 2021-05-14 | Sale | ZELDIS JEROME B | director | 3,000 <0.0001% | $0.90 | $2,701 | +1.43% | |
| 2021-05-14 | ZELDIS JEROME B | director | 3,000 <0.0001% | $0.89 | $2,664 | +1.43% | ||
| 2019-11-19 | SCHABER CHRISTOPHER J | Chairman, CEO and President | 10,770 0.0544% | $0.93 | $10,016 | +92.63% | ||
| 2019-11-19 | ZELDIS JEROME B | director | 2,000 0.0101% | $0.93 | $1,850 | +92.63% | ||
| 2019-09-23 | Parks Diane L. | director | 14,940 0.0003% | $0.93 | $13,870 | +95.33% | ||
| 2019-09-19 | ZELDIS JEROME B | director | 4,000 <0.0001% | $0.94 | $3,740 | +93.21% | ||
| 2019-04-22 | SCHABER CHRISTOPHER J | Chairman, CEO and President | 5,000 0.0001% | $0.72 | $3,577 | +47.89% | ||
| 2019-04-22 | ZELDIS JEROME B | director | 10,000 0.0002% | $0.73 | $7,274 | +47.89% | ||
| 2018-10-18 | SCHABER CHRISTOPHER J | Chairman, CEO and President | 8,700 0.0002% | $1.17 | $10,177 | -22.88% | ||
| 2018-10-17 | Pearson Mark E. | director | 170,000 0.0046% | $1.16 | $197,200 | -13.90% | ||
| 2018-08-22 | SCHABER CHRISTOPHER J | Chairman, CEO and President | 3,530 <0.0001% | $1.42 | $5,012 | -30.71% | ||
| 2017-11-29 | Sale | Essetifin SPA | 16,416 0.0012% | $2.12 | $34,802 | -19.31% | ||
| 2017-11-29 | Essetifin SPA | 293,510 0.0223% | $2.12 | $622,241 | -19.31% |
| CAVAZZA PAOLO | 10 percent owner | 54227816 249.146% | $19.31M | 3 | 0 | |
| CAVAZZA CLAUDIO | 10 percent owner | 54227816 249.146% | $19.31M | 3 | 0 | |
| BAM Management LLC | 10 percent owner | 21766092 100.0028% | $7.75M | 1 | 1 | |
| Pearson Mark E. | director | 2500000 11.4861% | $890,250.00 | 1 | 0 | |
| KANZER STEVE H | director | 1282203 5.891% | $456,592.49 | 1 | 0 | |
| LAPOINTE ANTHONY GREGG | director | 975610 4.4824% | $347,414.72 | 1 | 0 | |
| Essetifin SPA | 293510 1.3485% | $104,518.91 | 4 | 1 | ||
| MYRIANTHOPOULOS EVAN | Chief Financial Officer | 224780 1.0327% | $80,044.16 | 2 | 0 | |
| Clavijo James | Controller/Treasurer | 88191 0.4052% | $31,404.82 | 2 | 0 | |
| ZELDIS JEROME B | director | 25917 0.1191% | $9,229.04 | 6 | 1 | +47.03% |
| Brownlie Keith L | director | 19047 0.0875% | $6,782.64 | 1 | 0 | |
| SCHABER CHRISTOPHER J | CHAIRMAN, CEO AND PRESIDENT | 15511 0.0713% | $5,523.47 | 16 | 0 | +40.85% |
| Parks Diane L. | director | 14940 0.0686% | $5,320.13 | 1 | 0 | |
| Warusz Joseph Michael | VP of Finance/Acting CFO | 12955 0.0595% | $4,613.28 | 1 | 0 | |
| Guarino Jonathan L. | Senior Vice President and CFO | 11000 0.0505% | $3,917.10 | 2 | 0 | |
| Straube Richard | SENIOR VICE PRESIDENT AND CMO | 8000 0.0368% | $2,848.80 | 1 | 0 | |
| RUBIN ROBERT J. | director | 4385 0.0201% | $1,561.50 | 2 | 0 | |
| Brughera Marco Maria | director | 2750 0.0126% | $979.28 | 1 | 0 |
$13,664,154 | 40 | -70.35% | $7.05M | |
$29,645,465 | 28 | 8.09% | $6.48M | |
$812,698 | 12 | -57.09% | $7.89M | |
$4,146,041 | 11 | -40.86% | $8.55M | |
$252,503 | 11 | -13.65% | $6.41M |
| Increased Positions | 10 | +32.26% | 208,794 | +15.03% |
| Decreased Positions | 13 | -41.94% | 1M | -82.79% |
| New Positions | 5 | New | 104,078 | New |
| Sold Out Positions | 9 | Sold Out | 1M | Sold Out |
| Total Postitions | 28 | -9.68% | 447,928 | -67.77% |
| Armistice Capital, Llc | $1,005.00 | 7.08% | 708,000 | +708,000 | New | 2025-09-30 |
| Drw Securities, Llc | $243.00 | 1.71% | 171,422 | +171,422 | New | 2025-09-30 |
| Two Sigma Investments, Lp | $124.00 | 0.88% | 87,646 | +87,646 | New | 2025-09-30 |
| Sabby Management, Llc | $115.00 | 0.81% | 81,000 | +81,000 | New | 2025-09-30 |
| Renaissance Technologies Llc | $104.00 | 0.73% | 72,900 | +72,900 | New | 2025-09-30 |
| Hrt Financial Lp | $78.00 | 0.55% | 54,669 | +54,669 | New | 2025-09-30 |
| Vanguard Group Inc | $75.00 | 0.53% | 52,522 | +52,522 | New | 2025-09-30 |
| Virtu Financial Llc | $72.00 | 0.51% | 50,864 | +50,864 | New | 2025-09-30 |
| Banco Btg Pactual S.A. | $66.00 | 0.46% | 46,372 | +46,372 | New | 2025-09-30 |
| Geode Capital Management, Llc | $60.00 | 0.43% | 42,590 | +12,730 | +42.63% | 2025-09-30 |